STAAR Surgical (NASDAQ:STAA) reported its Q4 2024 earnings, revealing a significant miss on both earnings per share (EPS) and revenue compared to forecasts. The company posted an EPS of -$0.69, far ...
Mitolyn is a novel weight loss supplement that has been the subject of much discussion recently online. According to the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback